Search by Drug Name or NDC

NDC 11822-9994-02 Allergy relief-D 5; 120 mg/1; mg/1 Details

Allergy relief-D 5; 120 mg/1; mg/1

Allergy relief-D is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by RITE AID. The primary component is CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE.

MedlinePlus Drug Summary

Cetirizine injection is used to treat acute urticaria in adults and children 6 months of age or older. Cetirizine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.

Related Packages: 11822-9994-02
Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Cetirizine Injection

Pseudoephedrine is used to relieve nasal congestion caused by colds, allergies, and hay fever. It is also used to temporarily relieve sinus congestion and pressure. Pseudoephedrine will relieve symptoms but will not treat the cause of the symptoms or speed recovery. Pseudoephedrine is in a class of medications called nasal decongestants. It works by causing narrowing of the blood vessels in the nasal passages.

Related Packages: 11822-9994-02
Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Pseudoephedrine

Product Information

NDC	11822-9994
Product ID	11822-9994_e8846461-81e5-4bbd-876c-79f7bf8eb96c
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Allergy relief-D
Proprietary Name Suffix	n/a
Non-Proprietary Name	Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride
Product Type	HUMAN OTC DRUG
Dosage Form	TABLET, FILM COATED, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	5; 120
Active Ingredient Units	mg/1; mg/1
Substance Name	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
Labeler Name	RITE AID
Pharmaceutical Class	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA090922
Listing Certified Through	2024-12-31

Package

NDC 11822-9994-02 (11822999402)

Pricing Information	N/A
NDC Package Code	11822-9994-2
Billing NDC	11822999402
Package	6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (11822-9994-2)
Marketing Start Date	2023-07-20
NDC Exclude Flag	N